Literature DB >> 11253614

Indirect pharmacodynamic models for responses with multicompartmental distribution or polyexponential disposition.

W Krzyzanski1, W J Jusko.   

Abstract

Basic indirect response models where drug alters the production (kin) of the response variable (R) based on the Hill function previously assumed one-compartment distribution of the response variable and simple first-order loss (kout) of R. These models were extended using convolution theory to consideration of two-compartment distribution of R and/or polyexponential loss of R. Theoretical equations and methods of data analysis were developed and simulations are provided to demonstrate expected response behavior based on biexponential response dissipation. The inhibition model was applied to our previous data for inhibition of circadian cortisol secretion by prednisolone. The presence of multicompartment response variables and/or polyexponential loss complicates the response patterns and resolution of pharmacologic parameters of indirect response models and requires careful experimental and data analysis approaches in order to properly evaluate such pharmacodynamic responses. The occurrence of these alternative distribution or disposition components does not alter the area under the effect curve (AUCE) which remains identical to the basic models. Model misselection was addressed by testing fittings comparing the basic and new models. Use of the former for these more complex models does not severely perturb the calculated cardinal dynamic parameters. These models may provide improved insights into indirect responses with complexities in distribution or disposition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11253614     DOI: 10.1023/a:1011517718990

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  24 in total

1.  Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods.

Authors:  A Chakraborty; W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

2.  Mathematical formalism and characteristics of four basic models of indirect pharmacodynamic responses for drug infusions.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1998-08

3.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.

Authors:  A Sharma; W F Ebling; W J Jusko
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

Review 4.  Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.

Authors:  A Sharma; W J Jusko
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

5.  Integrated functions for four basic models of indirect pharmacodynamic response.

Authors:  W Krzyzanski; W J Jusko
Journal:  J Pharm Sci       Date:  1998-01       Impact factor: 3.534

6.  Estimation of pharmacokinetic parameters from postinfusion blood level data obtained after simultaneous administration of intravenous priming and infusion doses.

Authors:  S M Singhvi
Journal:  J Pharm Sci       Date:  1977-10       Impact factor: 3.534

Review 7.  Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems.

Authors:  D Verotta
Journal:  Crit Rev Biomed Eng       Date:  1996

8.  A program package for simulation and parameter estimation in pharmacokinetic systems.

Authors:  D Z D'Argenio; A Schumitzky
Journal:  Comput Programs Biomed       Date:  1979-03

9.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

10.  Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.

Authors:  A N Kong; E A Ludwig; R L Slaughter; P M DiStefano; J DeMasi; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1989-12       Impact factor: 6.875

View more
  9 in total

1.  Mathematical assessment of properties of precursor-dependent indirect pharmacodynamic response models.

Authors:  Anasuya Hazra; Wojciech Krzyzanski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-10-12       Impact factor: 2.745

2.  Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models.

Authors:  Xu Steven Xu; Hui Wang; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-03-31       Impact factor: 2.745

3.  Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.

Authors:  Jurgen B Bulitta; Cornelia B Landersdorfer
Journal:  AAPS J       Date:  2011-03-04       Impact factor: 4.009

4.  Indirect pharmacodynamic models for responses with circadian removal.

Authors:  Vivaswath S Ayyar; Wojciech Krzyzanski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-01-29       Impact factor: 2.745

Review 5.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

6.  Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.

Authors:  Dinko Rekić; Oskar Clewe; Daniel Röshammar; Leo Flamholc; Anders Sönnerborg; Vidar Ormaasen; Magnus Gisslén; Angela Abelö; Michael Ashton
Journal:  AAPS J       Date:  2011-09-13       Impact factor: 4.009

7.  Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race.

Authors:  M H Magee; R A Blum; C D Lates; W J Jusko
Journal:  J Clin Pharmacol       Date:  2001-11       Impact factor: 3.126

8.  A semi-physiological-based pharmacokinetic/pharmacodynamic model to describe the effects of topotecan on b-lymphocyte lineage cells.

Authors:  Nieves Vélez de Mendizábal; Iván Martínez-Forero; María J Garrido; Eva Bandrés; Jesús García-Foncillas; Cristina Segura; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2010-01-26       Impact factor: 4.200

9.  Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats.

Authors:  Damian Szczesny; Katarzyna Mołoniewicz; Michał J Markuszewski; Paweł Wiczling
Journal:  Pharmacol Rep       Date:  2020-08-03       Impact factor: 3.024

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.